Aurora Exports $10 Million In Cannabis To Israel
Aurora Cannabis (TSX: ACB) seemingly remains focused on growing its international medical cannabis operation. The firm this morning reported it
Read moreAurora Cannabis (TSX: ACB) seemingly remains focused on growing its international medical cannabis operation. The firm this morning reported it
Read moreAurora Cannabis (TSX:ACB) has reportedly entered into a licensing arrangement with 22nd Century Group (NASDAQ: XXII) and Cronos Group (TSX:
Read moreOn November 18th, Bank of America terminated coverage on Tilray Inc (TSX: TLRY) and Aurora Cannabis (TSX: ACB), citing a
Read moreOn November 9th, Aurora Cannabis (TSX: ACB) reported its fiscal first quarter financial results. The company reported total revenues of
Read moreAurora Cannabis (TSX: ACB) last night released its first quarter financial results, posting revenues of $60.1 million. The firm also
Read moreWith its Canadian market share falling apart, Aurora Cannabis (TSX: ACB) has evidently placed its focus on other markets. The
Read moreAurora Cannabis (TSX: ACB) appears to be in the process of changing its business model. The company this morning, despite
Read moreThree years into adult-use legalization – fewer than 1 in 5 CEOs who were there from the kick-off are still
Read moreThere is a common expression in the cannabis industry that “everything is more expensive.” Even in markets where the industry
Read moreOn September 27, Aurora Cannabis (TSX: ACB) reported its fiscal fourth quarter results. The companies results pointed to both a
Read more